Skip to main content
Erschienen in: Pediatric Nephrology 8/2006

01.08.2006 | Original Article

Compensatory renal growth protects mice against Shiga toxin 2-induced toxicity

verfasst von: Gabriela Verónica Camerano, Oscar David Bustuoabad, Roberto Pablo Meiss, Sonia Alejandra Gómez, Gabriela Cristina Fernández, Martín Amadeo Isturiz, Marina Sandra Palermo, Graciela Isabel Dran

Erschienen in: Pediatric Nephrology | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

Uninephrectomy (Unx) is followed by the compensatory renal growth (CRG) of the remaining kidney. Previous evidence has shown that during CRG, renal tissue is resistant to a variety of pathologies. We tested the hypothesis that the functional changes that take place during CRG could attenuate Shiga toxin (Stx) toxicity in a mouse model of Stx2-induced hemolytic uremic syndrome (HUS). The participation of nitric oxide (NO) was analyzed. After CRG induction with Unx, mice were exposed to a lethal dose of Stx2, and the degree of renal damage and mortality was measured. Stx2 effects on the growth, renal blood flow (RBF) and NO synthase (NOS) intrarenal expression in the remaining kidney were then studied. The induction of CRG strongly prevented Stx2-mediated mortality and renal damage. Administration of the NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME) during CRG partially impaired the protection. Both Stx2 and L-NAME interfered with the hypertrophic and hyperplastic responses to Unx, as well as with the increase in RBF. In intact mice, Stx2 decreased renal perfusion, inhibited endothelial NOS basal expression and enhanced inducible NOS expression; all of these effects were attenuated by prior Unx. It is concluded that during CRG mice are highly protected against Stx2 toxicity and lethality. The protective capacity of CRG could be related to the enhancement of renal perfusion and preservation of eNOS renal expression, counterbalancing two major pathogenic mechanisms of Stx2.
Literatur
2.
Zurück zum Zitat Wolf G, Neilson EG (1991) Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int 39:401–420PubMedCrossRef Wolf G, Neilson EG (1991) Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int 39:401–420PubMedCrossRef
4.
Zurück zum Zitat Lopez-Novoa JM, Ramos B, Martín-Oar JE, Hernando L (1982) Functional compensatory changes after unilateral nephrectomy in rats. General and intrarenal hemodynamic alterations. Renal Physiol 5:76–84PubMed Lopez-Novoa JM, Ramos B, Martín-Oar JE, Hernando L (1982) Functional compensatory changes after unilateral nephrectomy in rats. General and intrarenal hemodynamic alterations. Renal Physiol 5:76–84PubMed
5.
Zurück zum Zitat Ring K, Benson M, Bandyk M, Sawczuk I (1992) Detection of cellular proliferation during compensatory renal growth using flow cytometry. Nephron 61:200–203PubMedCrossRef Ring K, Benson M, Bandyk M, Sawczuk I (1992) Detection of cellular proliferation during compensatory renal growth using flow cytometry. Nephron 61:200–203PubMedCrossRef
6.
Zurück zum Zitat Ramos B, López-Novoa JM, Hernando L (1982) Role of hemodynamic alterations in the partial protection afforded by uninephrectomy against glycerol-induced acute renal failure in rats. Nephron 30:68–72PubMedCrossRef Ramos B, López-Novoa JM, Hernando L (1982) Role of hemodynamic alterations in the partial protection afforded by uninephrectomy against glycerol-induced acute renal failure in rats. Nephron 30:68–72PubMedCrossRef
7.
Zurück zum Zitat Fried TA, Hishida A, Barnes JL, Stein JH (1984) Ischemic acute renal failure in the rat: Protective effect of uninephrectomy. Am J Physiol 247:568–574 Fried TA, Hishida A, Barnes JL, Stein JH (1984) Ischemic acute renal failure in the rat: Protective effect of uninephrectomy. Am J Physiol 247:568–574
8.
Zurück zum Zitat Nakajima T, Miyaji T, Kato A, Ikegaya N, Yamamoto T, Hishida A (1996) Uninephrectomy reduces apoptotic cell death and enhances renal tubular regeneration in ischemic ARF in rats. Am J Physiol 271:846–853 Nakajima T, Miyaji T, Kato A, Ikegaya N, Yamamoto T, Hishida A (1996) Uninephrectomy reduces apoptotic cell death and enhances renal tubular regeneration in ischemic ARF in rats. Am J Physiol 271:846–853
9.
Zurück zum Zitat Kato A, Hishida A, Nakajima T (1995) Role of thromboxane A2 and prostacyclin in uninephrectomy-induced attenuation of ischemic renal injury. Kidney Int 48:1577–1583PubMedCrossRef Kato A, Hishida A, Nakajima T (1995) Role of thromboxane A2 and prostacyclin in uninephrectomy-induced attenuation of ischemic renal injury. Kidney Int 48:1577–1583PubMedCrossRef
10.
Zurück zum Zitat Kato A, Hishida A, Tanaka I, Komatsu K (1997) Uninephrectomy prevents the ischemia induced increase in renin activity. Nephron 75:72–76PubMedCrossRef Kato A, Hishida A, Tanaka I, Komatsu K (1997) Uninephrectomy prevents the ischemia induced increase in renin activity. Nephron 75:72–76PubMedCrossRef
11.
Zurück zum Zitat Kato A, Hishida A (2001) Amelioration of post-ischaemic renal injury by contralateral uninephrectomy: a role of endothelin-1. Nephrol Dial Transplant 16:1570–1576PubMedCrossRef Kato A, Hishida A (2001) Amelioration of post-ischaemic renal injury by contralateral uninephrectomy: a role of endothelin-1. Nephrol Dial Transplant 16:1570–1576PubMedCrossRef
12.
Zurück zum Zitat Ray PE, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823–839CrossRefPubMed Ray PE, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823–839CrossRefPubMed
13.
Zurück zum Zitat Obrig TG (1997) Shiga toxin mode of action in E. coli O157:H7 disease. Front Biosci 2:635–642CrossRef Obrig TG (1997) Shiga toxin mode of action in E. coli O157:H7 disease. Front Biosci 2:635–642CrossRef
14.
Zurück zum Zitat Karmali MA (2004) Infection by Shiga toxin-producing Escherichia coli: an overview. Mol Biotechnol 26:117–122PubMedCrossRef Karmali MA (2004) Infection by Shiga toxin-producing Escherichia coli: an overview. Mol Biotechnol 26:117–122PubMedCrossRef
15.
Zurück zum Zitat Cotran RS, Kumar V, Collins T (1999) Robbin’s pathologic basis of disease. WB Saunders, Philadelphia, PA, pp 969 Cotran RS, Kumar V, Collins T (1999) Robbin’s pathologic basis of disease. WB Saunders, Philadelphia, PA, pp 969
16.
Zurück zum Zitat Fernandez GC, Te Loo MW, van der Velden TJ, van der Heuvel LP, Palermo MS, Monnens LL (2003) Decrease in thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome. Pediatr Nephrol 18:1066–1068PubMedCrossRef Fernandez GC, Te Loo MW, van der Velden TJ, van der Heuvel LP, Palermo MS, Monnens LL (2003) Decrease in thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome. Pediatr Nephrol 18:1066–1068PubMedCrossRef
17.
Zurück zum Zitat Te Loo M, Bosma N, Van Hinsbergh V, Span P, De Waal R, Clarijs R, Sweep C, Monnens L, van der Heuvel L (2004) Elevated levels of vascular endothelial growth factor in serum of patients with D-HUS. Pediatr Nephrol 19:754–760CrossRef Te Loo M, Bosma N, Van Hinsbergh V, Span P, De Waal R, Clarijs R, Sweep C, Monnens L, van der Heuvel L (2004) Elevated levels of vascular endothelial growth factor in serum of patients with D-HUS. Pediatr Nephrol 19:754–760CrossRef
18.
Zurück zum Zitat Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109–142PubMed Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109–142PubMed
19.
Zurück zum Zitat Morris SM, Billiar TR (1994) New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266:829–839CrossRef Morris SM, Billiar TR (1994) New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266:829–839CrossRef
20.
Zurück zum Zitat Noris M, Ruggenenti P, Todeschini M, Figliuzzi M, Macconi D, Zoja C, Paris S, Gaspari F, Remuzzi G (1996) Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injury. Am J Kidney Dis 27:790–796PubMedCrossRef Noris M, Ruggenenti P, Todeschini M, Figliuzzi M, Macconi D, Zoja C, Paris S, Gaspari F, Remuzzi G (1996) Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injury. Am J Kidney Dis 27:790–796PubMedCrossRef
21.
Zurück zum Zitat Dran G, Fernández GC, Rubel CJ, Bermejo E, Gomez S, Isturiz MA, Palermo M (2002) Participation of L-arginine-nitric oxide pathway in the pathogenesis of hemolytic uremic syndrome in a murine model. Kidney Int 62:1338–1348PubMedCrossRef Dran G, Fernández GC, Rubel CJ, Bermejo E, Gomez S, Isturiz MA, Palermo M (2002) Participation of L-arginine-nitric oxide pathway in the pathogenesis of hemolytic uremic syndrome in a murine model. Kidney Int 62:1338–1348PubMedCrossRef
22.
Zurück zum Zitat Valdivielso JM, Perez-Barriocanal F, García-Estan J, López-Novoa JM (1999) Role of nitric oxide in the early renal hemodynamic response after unilateral nephrectomy. Am J Physiol 276:1718–1723 Valdivielso JM, Perez-Barriocanal F, García-Estan J, López-Novoa JM (1999) Role of nitric oxide in the early renal hemodynamic response after unilateral nephrectomy. Am J Physiol 276:1718–1723
23.
Zurück zum Zitat Sigmon DH, Gonzalez-Feldman E, Cavasin MA, Potter DL, Beierwaltes WH (2004) Role of nitric oxide in the renal hemodynamic response to unilateral nephrectomy. J Am Soc Nephrol 15:1413–1420PubMedCrossRef Sigmon DH, Gonzalez-Feldman E, Cavasin MA, Potter DL, Beierwaltes WH (2004) Role of nitric oxide in the renal hemodynamic response to unilateral nephrectomy. J Am Soc Nephrol 15:1413–1420PubMedCrossRef
24.
Zurück zum Zitat Tolins JP, Palmer RM, Moncada S, Raij L (1990) Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 258:655–662 Tolins JP, Palmer RM, Moncada S, Raij L (1990) Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 258:655–662
25.
26.
Zurück zum Zitat Perico N, Remuzzi G (2002) Nitric oxide and renal perfusion in humans. J Hypertens 20:391–393PubMedCrossRef Perico N, Remuzzi G (2002) Nitric oxide and renal perfusion in humans. J Hypertens 20:391–393PubMedCrossRef
27.
Zurück zum Zitat Jansen A, Cook T, Michael T, Largen P, Riveros MV, Moncada S, Cattell V (1994) Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int 45:1215–1219PubMedCrossRef Jansen A, Cook T, Michael T, Largen P, Riveros MV, Moncada S, Cattell V (1994) Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int 45:1215–1219PubMedCrossRef
28.
Zurück zum Zitat Furusu A, Miyasaki M, Abe K, Tsukasaki S, Shioshita K, Sasaki O, Miyasaki K, Ozono Y, Koji T, Harada T, Sakai H, Kohno S (1998) Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 53:1760–1768PubMedCrossRef Furusu A, Miyasaki M, Abe K, Tsukasaki S, Shioshita K, Sasaki O, Miyasaki K, Ozono Y, Koji T, Harada T, Sakai H, Kohno S (1998) Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 53:1760–1768PubMedCrossRef
29.
Zurück zum Zitat Zhou XI, Laszik Z, Ni Z, Wang XQ, Brackett DJ, Lerner MR, Silva FG, Vaziri ND (2000) Down regulation of renal endothelial nitric oxide synthase expression in experimental glomerular thrombotic microangiopathy. Lab Invest 80:1079–1087PubMedCrossRef Zhou XI, Laszik Z, Ni Z, Wang XQ, Brackett DJ, Lerner MR, Silva FG, Vaziri ND (2000) Down regulation of renal endothelial nitric oxide synthase expression in experimental glomerular thrombotic microangiopathy. Lab Invest 80:1079–1087PubMedCrossRef
30.
Zurück zum Zitat Palermo MS, Alves Rosa MF, Rubel C, Fernández GC, Fernández Alonso G, Alberto F, Rivas M, Isturiz MA (2000) Pretreatment of mice with lipopolysaccharide (LPS) or IL1β exerts dose-dependent opposite effects on Shiga toxin-2 lethality. Clin Exp Immunol 119:77–83 Palermo MS, Alves Rosa MF, Rubel C, Fernández GC, Fernández Alonso G, Alberto F, Rivas M, Isturiz MA (2000) Pretreatment of mice with lipopolysaccharide (LPS) or IL1β exerts dose-dependent opposite effects on Shiga toxin-2 lethality. Clin Exp Immunol 119:77–83
31.
Zurück zum Zitat National Institutes of Health (NIH) (1985) Guide for the care and use of laboratory animals. Government Printing Office, Washington, DC National Institutes of Health (NIH) (1985) Guide for the care and use of laboratory animals. Government Printing Office, Washington, DC
32.
Zurück zum Zitat Orucevic A, Lala PK (1996) N-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumor growth in adenocarcinoma-bearing mice. Br J Cancer 73:189–196PubMedPubMedCentralCrossRef Orucevic A, Lala PK (1996) N-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumor growth in adenocarcinoma-bearing mice. Br J Cancer 73:189–196PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Bradford MM (1976) A rapid and sensitive method for the quantification of microgram of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRef Bradford MM (1976) A rapid and sensitive method for the quantification of microgram of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRef
34.
Zurück zum Zitat Kasina S, Fritzberg AR, Johnson DL, Eshima D (1986) Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as a renal radiopharmaceutical. J Med Chem 29:1933–1940PubMedCrossRef Kasina S, Fritzberg AR, Johnson DL, Eshima D (1986) Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as a renal radiopharmaceutical. J Med Chem 29:1933–1940PubMedCrossRef
35.
Zurück zum Zitat Ercan MT, Gulaldi NC, Unsal IS, Aydin M, Peksoy I, Hascelik Z (1996) Evaluation of Tc-99m (V) DMSA for imaging inflammatory lesions: an experimental study. Ann Nucl Med 10:419–423PubMedCrossRef Ercan MT, Gulaldi NC, Unsal IS, Aydin M, Peksoy I, Hascelik Z (1996) Evaluation of Tc-99m (V) DMSA for imaging inflammatory lesions: an experimental study. Ann Nucl Med 10:419–423PubMedCrossRef
36.
Zurück zum Zitat Rosignoli F, Goren N, Perez Leirós C (1986) Alterations in nitric oxide synthase activity and expression in submandibular glands of NOD mice. Clin Immunol 101:86–93CrossRef Rosignoli F, Goren N, Perez Leirós C (1986) Alterations in nitric oxide synthase activity and expression in submandibular glands of NOD mice. Clin Immunol 101:86–93CrossRef
37.
Zurück zum Zitat Ikeda M, Ito S, Honda M (2004) Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Pediatr Nephrol 19:485–489PubMedCrossRef Ikeda M, Ito S, Honda M (2004) Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Pediatr Nephrol 19:485–489PubMedCrossRef
38.
Zurück zum Zitat Obrig TG, Del Vecchio PJ, Brown JE, Moran TP, Rowland BM, Judge TK, Rothman SW (1988) Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 56:2373–2378PubMedPubMedCentral Obrig TG, Del Vecchio PJ, Brown JE, Moran TP, Rowland BM, Judge TK, Rothman SW (1988) Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 56:2373–2378PubMedPubMedCentral
39.
Zurück zum Zitat Majoul I, Schmidt T, Pomasanova M, Boutkevich E, Kozlov Y, Soling HD (2002) Differential expression of receptors for Shiga and Cholera toxins is regulated by the cell cycle. J Cell Sci 115:817–826PubMed Majoul I, Schmidt T, Pomasanova M, Boutkevich E, Kozlov Y, Soling HD (2002) Differential expression of receptors for Shiga and Cholera toxins is regulated by the cell cycle. J Cell Sci 115:817–826PubMed
40.
Zurück zum Zitat Scholbach TM (1986) Changes of renal flow volume in the hemolytic uremic syndrome—Color Doppler sonographic investigations. Pedriatr Nephrol 16:644–647CrossRef Scholbach TM (1986) Changes of renal flow volume in the hemolytic uremic syndrome—Color Doppler sonographic investigations. Pedriatr Nephrol 16:644–647CrossRef
41.
Zurück zum Zitat West JB (1991) Physiological basis of medical practice, 12th edn. Waverly, Baltimore, MD, pp 530 West JB (1991) Physiological basis of medical practice, 12th edn. Waverly, Baltimore, MD, pp 530
43.
Zurück zum Zitat Karlberg L, Norlen BJ, Ojteg G, Wolgast M (1983) Impaired medullary circulation in postischemic acute renal failure. Acta Physiol Scand 118:11–17PubMedCrossRef Karlberg L, Norlen BJ, Ojteg G, Wolgast M (1983) Impaired medullary circulation in postischemic acute renal failure. Acta Physiol Scand 118:11–17PubMedCrossRef
44.
Zurück zum Zitat Brezis MS, Rosen S, Silva RP, Epstein FH (1984) Renal ischemia. A new perspective. Kidney Int 26:375–383PubMedCrossRef Brezis MS, Rosen S, Silva RP, Epstein FH (1984) Renal ischemia. A new perspective. Kidney Int 26:375–383PubMedCrossRef
45.
Zurück zum Zitat Schwartz D, Mendonca M, Schwartz I, Xia Y, Satriano J, Wilson CB, Blantz RC (1997) Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100:439–448PubMedPubMedCentralCrossRef Schwartz D, Mendonca M, Schwartz I, Xia Y, Satriano J, Wilson CB, Blantz RC (1997) Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100:439–448PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Williams JM, Lote CJ, Thewels A, Wood JA, Howie AJ, Williams DA, Taylor M (2000) Role of nitric oxide in a toxin-induced model of haemolytic uremic syndrome. Pediatr Nephrol 14:1066–1070PubMedCrossRef Williams JM, Lote CJ, Thewels A, Wood JA, Howie AJ, Williams DA, Taylor M (2000) Role of nitric oxide in a toxin-induced model of haemolytic uremic syndrome. Pediatr Nephrol 14:1066–1070PubMedCrossRef
47.
Zurück zum Zitat Aka JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI (2005) Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115:e673–e680CrossRef Aka JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI (2005) Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115:e673–e680CrossRef
Metadaten
Titel
Compensatory renal growth protects mice against Shiga toxin 2-induced toxicity
verfasst von
Gabriela Verónica Camerano
Oscar David Bustuoabad
Roberto Pablo Meiss
Sonia Alejandra Gómez
Gabriela Cristina Fernández
Martín Amadeo Isturiz
Marina Sandra Palermo
Graciela Isabel Dran
Publikationsdatum
01.08.2006
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 8/2006
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0115-5

Weitere Artikel der Ausgabe 8/2006

Pediatric Nephrology 8/2006 Zur Ausgabe

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.